Therapy News and Research

RSS
Adults with moderate to severe TBI may be at greater risk of death from unintentional injuries

Adults with moderate to severe TBI may be at greater risk of death from unintentional injuries

Fluid-filled sacs that brain cells make to trap amyloid may contribute to Alzheimer's disease

Fluid-filled sacs that brain cells make to trap amyloid may contribute to Alzheimer's disease

Platelet function testing in elderly patients after heart attack shows no improved outcomes

Platelet function testing in elderly patients after heart attack shows no improved outcomes

Lipoprotein apheresis may have new role in patients with refractory angina

Lipoprotein apheresis may have new role in patients with refractory angina

Active strategy of detecting and treating asymptomatic MSAD results in no clinical benefit

Active strategy of detecting and treating asymptomatic MSAD results in no clinical benefit

Remote monitoring shows no improvement in outcomes for heart failure patients with CIEDs

Remote monitoring shows no improvement in outcomes for heart failure patients with CIEDs

HIJ-PROPER trial: Intensive cholesterol-lowering regimen in ACS patients shows no better outcomes

HIJ-PROPER trial: Intensive cholesterol-lowering regimen in ACS patients shows no better outcomes

Less invasive infusion strategy not linked to cardiac functional improvements but enhances health status

Less invasive infusion strategy not linked to cardiac functional improvements but enhances health status

PCSK9 inhibitor can reduce need for apheresis treatment in patients with familial hypercholesterolemia

PCSK9 inhibitor can reduce need for apheresis treatment in patients with familial hypercholesterolemia

Large cardiopoietic regenerative therapy trial for patients with congestive heart failure reveals new insights

Large cardiopoietic regenerative therapy trial for patients with congestive heart failure reveals new insights

Janssen seeks to extend DARZALEX license to benefit more multiple myeloma patients

Janssen seeks to extend DARZALEX license to benefit more multiple myeloma patients

Study results confirm safety and efficacy of INSIGHTEC’s Exablate Neuro system for the  treatment of essential tremor

Study results confirm safety and efficacy of INSIGHTEC’s Exablate Neuro system for the treatment of essential tremor

NEJM publishes MINDACT trial results

NEJM publishes MINDACT trial results

Study shows non-inferiority of short-term dual antiplatelet therapy in patients with DES placement

Study shows non-inferiority of short-term dual antiplatelet therapy in patients with DES placement

Engineered gut bacteria may one day help reduce negative health effects of obesity

Engineered gut bacteria may one day help reduce negative health effects of obesity

Alcohol-related hospitalisation linked to increased risk of ischaemic stroke in atrial fibrillation patients

Alcohol-related hospitalisation linked to increased risk of ischaemic stroke in atrial fibrillation patients

Direct catheter-based thrombectomy equally effective to bridging thrombolysis in acute ischaemic stroke

Direct catheter-based thrombectomy equally effective to bridging thrombolysis in acute ischaemic stroke

ESC releases novel position paper on tackling cardiotoxicity of anticancer treatments

ESC releases novel position paper on tackling cardiotoxicity of anticancer treatments

MRI-guided focused ultrasound treatment improves quality of life in patients with essential tremor

MRI-guided focused ultrasound treatment improves quality of life in patients with essential tremor

First ESC Guidelines on Atrial Fibrillation published online

First ESC Guidelines on Atrial Fibrillation published online

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.